St. Jude Medical resolves VA civil lawsuit; Pharmaceutical Innovations recalls ultrasound gel

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> St. Jude Medical ($STJ) will pay almost $3.7 million to settle a civil lawsuit that accused the medical device company of not rebating the federal government for pacemakers and defibrillators that had to be removed from patients. Story

> In the fight to repeal the 2.3% device tax, industry leaders can thank Rep. Erik Paulsen (R-MN) for leading the charge in Congress. Story

> Germany's MagForce, whose signature NanoThermR nanotech device treats brain tumors, has inked a distribution deal with Turkey's Tek Grup Inc. The firm will bring the device to Turkey, Albania, Iraq and Azerbaijan. Release

> MRI Interventions, which makes minimally invasive neurosurgery systems, has launched an initial public offering at $1 per share (OTC: $MRIC). Story

> Pharmaceutical Innovations is recalling its Other-Sonic generic ultrasound transmission gel because of possible microbial contamination, according to the FDA. Listing

> Edwards Lifesciences ($EW) is recalling some lots of its Perimount replacement heart valves. The reason: They may have been contaminated with tiny metal particles during the packaging process. Story

> ViewRay gained 510(k) clearance for its MRI-based system that delivers radiation therapy to cancer patients. Story

> Amedica Corp. has promoted Bryan McEntire to chief technology officer. He previously served as vice president of manufacturing and R&D for the maker of medical grade silicon nitride for spine, total joint and dental devices. Release

Biotech News

 @FierceBiotech: NIH group to award up to $20B in IT contracts. News | Follow @FierceBiotech

 @JohnCFierce: Lilly still building its data on Livalo (statin) compared to Pravachol. Are they making any sales yet? Tough biz: Release | Follow @JohnCFierce

 @RyanMFierce: After Stiefel/GSK deal, Canadian biotech Welichem's shares slide 18.75%, or CAD 9 cents. More | Follow @RyanMFierce

> Sanofi R&D chief spotlights diabetes strategy amid Amylin bid buzz. Story

> Chelsea scuttles rheumatoid arthritis drug after PhII failure, shares dive. Article

> House stamps approval on fast-track approach to drug development. More

Pharma News

 @FiercePharma: Icahn's back after Forest Labs, plans to nominate board candidates, including crony Eric Ende--BW. News | Follow @FiercePharma

> Reuters: Glaxo aims to replace entire HGS board. News

> CVS takes aim at co-pay cards by blocking drug coverage. Story

Pharma Manufacturing News

> Another Indian drugmaker expanding in Nigeria. Item

> Fake Adderall surfaces as Congress turns attention to track and trace. More

> China's Biostar says it has replaced 5M tainted capsules. News

> FDA spanks J&J McNeil plant over complaint failures. Article

Vaccines News

> Bionor's new HIV vaccine moves into clinical trials. News

> Oral TB vax could cut treatment time. More

> Making safer and better shots. Story

> Merck's RotaTeq will be saving lives in Rwanda. Item

CRO News

 @NesaNFierce: Frazier Healthcare will buy Catalent's Philly and Woodstock, IL commercial packaging ops, but both parties are mum on the deal's cost. News | Follow @NesaNFierce

> Catalent to sell its U.S. commercial packaging ops to VC group Frazier Healthcare. Article

> New CRO Agility Clinical to focus on pediatric and orphan diseases. Story

> CMO revenue expected to double in Europe in 6 years. Item

> Covance, Bayer Healthcare enter strategic R&D partnership. News

And Finally ... The Wolverine Venture Fund recently participated in the $25 million Series D round for Sonitus Medical, which is developing a bone-conduction hearing aid. Students in the University of Michigan's MBA entrepreneurship program manage the fund, which focuses on life sciences and medical sectors. Story